Navigation Links
European Urological Device Market Will Be Driven By Adoption Of New Minimally Invasive Devices
Date:8/1/2013

TORONTO, Aug. 1, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, patient and hospital demand for minimally invasive and discreet devices is rising within European markets for urological devices, and products that meet these needs are poised to see strong adoption through 2021.

(Logo:  http://photos.prnewswire.com/prnh/20130103/MM36799LOGO)

Minimally invasive products stand to gain significant adoption because these devices require shorter operation times and result in reduced patient pain. For example, EDAP TMS' Focal.One high-intensity focused ultrasound (HIFU) system, which received CE marking in June 2013, uses advanced imaging and robotic technology to target specific areas of the prostate for prostate cancer treatment. This product will help to address the demand for less invasive focal prostate cancer therapy, which can potentially reduce complications because the entire gland is not treated. The Focal.One will therefore see growing adoption through 2021.

"The demand for minimally invasive treatments is also driving a shift toward flexible endoscopy for many procedures," said MRG Analyst Jennifer Smith. "Flexible endoscopy decreases tissue trauma and can reach more anatomy than is possible during rigid endoscopy. The increasing use of this treatment will support demand for flexible endoscopes as well as for devices used during flexible endoscopy procedures, like tipless nitinol stone retrieval devices and holmium lasers used in stone management procedures."

In addition, many innovations are aimed at making urological devices more discreet, given that patients are self-conscious about these products. The urinary incontinence device market in particular has seen a marked shift toward discreet devices; intermittent catheters generated the majority of revenues in this segment in 2012 because these devices allow for self-catheterization and also offer a reduced risk of urinary tract infections compared to Foley catheters. An example of an innovation in this space is Coloplast's Speedicath Compact Set, a product that is designed to make catheterization more discreet for wheelchair users.

Millennium Research Group's European Markets for Urological Devices 2013 and European Markets for Urological Devices 2013 (Part 2) reports include procedure, unit, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for urinary incontinence devices, stone management devices, benign prostatic hyperplasia devices, urological endoscopes, prostate cancer treatment devices and erectile dysfunction treatment devices in France, Germany, Italy, Spain, the United Kingdom, Belgium, the Netherlands, Sweden and Switzerland. Supplemental country coverage is also available for Austria, the Czech Republic, Denmark, Finland, Greece, Hungary, Norway, Poland, Portugal, Romania and Ukraine, as well as in aggregate for the rest of the European countries.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Christopher Comfort
Decision Resources Group
781-993-2597
ccomfort@dresources.com

Alex Jablokow
Millennium Research Group
617-599-8613
ajablokow@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
2. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
3. Marken Acquires European Kit Building Operation From LabCorp Clinical Trials
4. Blood Disorders: European Hematologists Gather in Amsterdam, June 14-17, 2012
5. Mylan Launches Generic Lipitor® in Five European Countries
6. European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan
7. Bristol-Myers Squibb to Present New Data on ORENCIA(R)? (abatacept) at the European League Against Rheumatism (EULAR) 2012 Congress
8. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
9. Study Results of Novocures NovoTTF™ Pivotal Phase 3 Trial Published in European Journal of Cancer
10. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
11. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)... , May 9, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced it has earned a spot ... 2017" list. The Company was ranked among 500 U.S. ... Employers and Healthcare Equipment and Services. The ... on an anonymous, independent survey of over 30,000 employees ...
(Date:5/9/2017)... 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug ... Property Office has granted Oramed a patent titled, ... The patent covers Oramed,s invention of an oral ... an incretin hormone that stimulates the secretion of ...
(Date:5/8/2017)... NEW YORK , May 8, 2017 ... in the transition from fee for service reimbursement. Black ... April 2017. 1.       The Market for ... 77% of physician practices with 3 or ... Compliance Technology Solutions by Q4. "Given the magnitude of ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... May 26, 2017 , ... Rob Lowe acts as ... production of the series is on hiking in American. Viewers can reconnect with America ... great benefits of hiking. , Many consumers have looked for an inventive new place ...
(Date:5/26/2017)... ... ... FAMILY-Our Journey to the Cross”: the personal journey of Bob Massey and his faith in ... authors, Bob and Margaret Massey. Bob Massey is small in stature but big in ... His love for others is apparent in all of his life decisions. , ...
(Date:5/26/2017)... ... ... “Cactus Jack: Against All Odds”: the story of Coach Cactus Jack and the ... is the creation of published author, Walter Hubbard, a retired wildlife and fisheries biologist ... Jane. Walter. Walter and Jane have three adult children and a granddaughter. ...
(Date:5/24/2017)... ... May 24, 2017 , ... In ... choosing the most appropriate instruments for research and understanding the basic principles that ... webinar will focus on innovations in stereo microscopy for brightfield and fluorescence typically ...
(Date:5/24/2017)... ... May 24, 2017 , ... NucleusHealth ™, ... has received U.S. Food and Drug Administration (FDA) 510(k) clearance for ... secure cloud platform for medical image management. At the core is patented streaming ...
Breaking Medicine News(10 mins):